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ABSTRACT Endocytic transport necessitates the generation of membrane tubules and their 
subsequent fission to transport vesicles for sorting of cargo molecules. The endocytic recy-
cling compartment, an array of tubular and vesicular membranes decorated by the Eps15 
homology domain protein, EHD1, is responsible for receptor and lipid recycling to the plasma 
membrane. It has been proposed that EHD dimers bind and bend membranes, thus generat-
ing recycling endosome (RE) tubules. However, recent studies show that molecules interact-
ing with CasL-Like1 (MICAL-L1), a second, recently identified RE tubule marker, recruits EHD1 
to preexisting tubules. The mechanisms and events supporting the generation of tubular re-
cycling endosomes were unclear. Here, we propose a mechanism for the biogenesis of RE 
tubules. We demonstrate that MICAL-L1 and the BAR-domain protein syndapin2 bind to 
phosphatidic acid, which we identify as a novel lipid component of RE. Our studies demon-
strate that direct interactions between these two proteins stabilize their association with 
membranes, allowing for nucleation of tubules by syndapin2. Indeed, the presence of phos-
phatidic acid in liposomes enhances the ability of syndapin2 to tubulate membranes in vitro. 
Overall our results highlight a new role for phosphatidic acid in endocytic recycling and pro-
vide new insights into the mechanisms by which tubular REs are generated.
INTRODUCTION
Mammalian cells constantly sample the extracellular milieu and in-
ternalize receptors, ligands, nutrients, and plasma membrane con-
stituents, which include proteins and lipids. Accordingly, a high level 
of endocytic regulation is required to maintain the fine balance be-
tween internalized molecules and those returned to the plasma 
membrane through the process of recycling. In addition to maintain-
ing cell shape by the return of lipids and receptors to the plasma 
membrane, endocytic recycling has specific effects on a variety of 
cellular processes. For example, studies show that vesicles involved 
in furrow cleavage and cytokinesis originate in part from recycling 
endosomes (Montagnac et al., 2008), as well as from the process of 
abscission, in which the cytokinetic bridge is severed (Skop et al., 
2001; Fielding et al., 2005). Recycling also plays a crucial role in cell 
adhesion, spreading, and migration (Caswell and Norman, 2008) 
and has specialized roles in maintaining epithelial polarization (Wang 
et al., 2000), regulating cell fusion in myoblasts (Doherty et al., 
2008), and controlling α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid receptors in neurons (Park et al., 2004).
A wide array of proteins regulate endocytic recycling; notably, 
the Rab-family proteins Rab11 and Rab4, as well as Rab21, Rab22, 
Rab8, Rab15, and Rab35 (Grant and Donaldson, 2009; Hsu and 
Prekeris, 2010). Various Rab effectors also control recycling 
(Grosshans et al., 2006), some of which interact with the C-terminal 
Eps15 homology domain protein 1 (EHD1), another known regula-
tor of endocytic recycling (Naslavsky and Caplan, 2011). Studies 
demonstrated that EHD1 depletion affects the recycling of multiple 
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To gain insight into the mechanism of RE tubule biogenesis, we 
identified Synd2 as a third marker protein of RE tubules (colocalizing 
with EHD1 and MICAL-L1). We discovered that the Synd2 SH3 
domain interacts directly with MICAL-L1 through two of the latter’s 
14 proline-rich domains (PRDs) and that this interaction is needed 
for the stable association of proteins on membranes and the nucle-
ation of membrane tubules. We also identified MICAL-L1 and Synd2 
as two of only a handful of known phosphatidic acid (PA)–binding 
proteins. Our study indicates that PA is an essential lipid component 
of RE tubules and that the presence of PA enhances Synd2 F-BAR 
tubulation activity. In addition, impairment of PA synthesis with in-
hibitors significantly delays endocytic recycling. These results pro-
mote a new model suggesting that 1) local lipid concentration of PA 
in membranes facilitates the independent binding of MICAL-L1 and 
Synd2 to these membranes, 2) association of MICAL-L1 and Synd2 
with membranes is stabilized upon their interaction, and 3) this inter-
action on membranes leads to tubule biogenesis by the Synd2 
F-BAR domain. We propose that EHD1 is recruited to tubular RE 
by MICAL-L1 and/or Synd2, where it performs scission to facilitate 
vesicle transport and recycling to the plasma membrane.
RESULTS
Synd2/MICAL-L1/EHD1 exists as a complex decorating 
tubular recycling endosomes
Initially, we evaluated the ability of EHD1 to localize to tubular REs in 
the absence of both Bin1 and Synd2 (with MICAL-L1 as a positive 
control). Although EHD1 remained closely associated with tubular 
REs in the absence of Bin1, depletion of either Synd2 or MICAL-L1 
induced the loss of EHD1 localization to tubules (Supplemental 
Figure S1, A and B). Of the three syndapins, only Synd2 is ubiqui-
tously expressed and was therefore chosen to assess whether it in-
teracts with MICAL-L1 and forms a complex. In support of this idea, 
a recent large-scale proteomic study found a potential interaction 
between the SH3 domain of Synd2 and MICAL-L1 (Linkermann 
et al., 2009). To see whether Synd2 and MICAL-L1 interact in vivo, 
we performed coimmunoprecipitation experiments. HeLa cells were 
transfected either with hemagglutinin (HA)-Synd2 or HA-JNK1 
(control) and pulled down with antibodies to endogenous MICAL-
L1. We found that Synd2, but not JNK1, coimmunoprecipitated with 
MICAL-L1, indicating that MICAL-L1 and Synd2 can interact in vivo 
(Figure 1B). We next assessed whether the MICAL-L1-Synd2 interac-
tion occurs via EHD1. Because MICAL-L1 and Synd2 both have NPF 
motifs that interact with EHD1 (Braun et al., 2005; Sharma et al., 
2009), glutathione S-transferase (GST) pull-down and yeast two-hy-
brid experiments were done to determine whether EHD1 mediates 
this interaction. GST pull-down experiments with GST alone (control), 
GST fused to full-length Synd2, or GST fused to a series of Synd2 
truncation/deletions mutants was done using bovine brain cytosol. 
Whereas GST-Synd2 precipitated both MICAL-L1 and EHD1 (Figure 
1C), GST alone did not pull down either protein. Removal of the 
Synd2 SH3 domain (Synd2 ΔSH3) but not its NPF motifs led to a loss 
of interaction with MICAL-L1 but not EHD1, indicating that Synd2 
interacts with MICAL-L1 through its SH3 domain. Furthermore, when 
pull-downs were done with only the Synd2 SH3 domain, MICAL-L1 
but not EHD1 was precipitated. Mutation of all Synd2 NPF motifs to 
APA (GST-Synd2-NPF → APA) or a Synd2 truncation containing only 
its F-BAR domain (GST-Synd2 F-BAR, which lacks NPF motifs) pre-
vented its interaction with EHD1, as expected. Our studies lead us 
to conclude that the interactions between Synd2, MICAL-L1, and 
EHD1 are mutually exclusive and direct.
We next determined which of the 14 PRDs contained by 
MICAL-L1 are required to interact with the Synd2 SH3 domain. As 
receptors that are internalized both through clathrin-coated pits and 
independent of clathrin, including transferrin receptor (Lin et al., 
2001), major histocompatibility complex class I proteins (Caplan 
et al., 2002), GLUT4 transporters, and other channels (Guilherme 
et al., 2004). β1 integrins are also subject to EHD1 regulation (Jovic 
et al., 2007), suggesting a rationale for the significance of recycling 
in cell migration.
Recent studies provided molecular and atomic mechanisms ex-
plaining the function of EHD1. The nuclear magnetic resonance 
solution structure of the EHD1 EH domain (Kieken et al., 2007) led 
to the identification of novel interaction partners containing aspar-
agine–proline–phenylalanine (NPF) motifs followed by acidic resi-
dues that selectively interact with the positively charged EH domain 
electrostatic surface area (Henry et al., 2010; Kieken et al., 2010). 
Perhaps most striking are recent studies providing evidence that 
EHD proteins serve as dynamin-like ATPases (Lee et al., 2005; 
Daumke et al., 2007; Jakobsson et al., 2011; Cai et al., 2012), sug-
gesting an important role for the protein in the scission of vesicles 
destined to be recycled back to the plasma membrane from the 
endocytic recycling compartment (ERC).
EHD1 and its Caenorhabditis elegans orthologue, Rme1, con-
trol the morphology of the ERC (Grant et al., 2001), which is a 
complex network of tubular and vesicular membranes, concen-
trated in some cells to the juxtanuclear region (Maxfield and 
McGraw, 2004). EHD1 localizes to and is the best-known marker 
of large recycling tubules, whose diameter can reach up to 200 nm 
(Caplan et al., 2002). Tubular intermediates play important roles in 
sorting and cargo selection (reviewed in Maxfield and McGraw, 
2004). It was suggested that due to the high surface-to-volume 
ratio of tubular endosomes, membranes and recycling receptors 
can be preferentially segregated from soluble cargo in early/
sorting endosomes (Maxfield and McGraw, 2004). Similar mecha-
nisms are predicted for exit of receptors from the ERC to the 
plasma membrane.
Although evidence supports the notion that EHD1 localizes to 
tubular recycling endosomes and functions as a “pinchase” in 
membrane constriction and scission, the mode of biogenesis of 
these unique tubular membranes has remained an enigma. 
Although in vitro experiments show that EHD proteins are capable 
of inducing lipid tubulation (Daumke et al., 2007; Pant et al., 2009), 
studies in cells are not entirely consistent with this notion. For 
example, the recent identification of Molecules Interacting with 
CAsL-Like1 (MICAL-L1; see Figure 1A) as a novel tubular recycling 
endosome (RE) marker, EHD1 interaction partner (Sharma et al., 
2009), and membrane hub (Rahajeng et al., 2012) has challenged 
this view. MICAL-L1, originally identified as an NPF-containing pro-
tein that binds to the EHD1 EH domain through its acidic-flanked 
NPF motif (Kieken et al., 2010), recruits both EHD1 and Rab8 to 
tubular REs (Sharma et al., 2009). However, depletion of EHD1 has 
no effect on the association of MICAL-L1 with tubular REs, demon-
strating that they are generated and maintained even in the absence 
of EHD1 (Sharma et al., 2009).
For this study, we proposed that the recruitment of protein(s) 
containing membrane-sensing and curvature-inducing BAR do-
mains may result in RE tubulation. Such BAR domain–containing 
proteins induce membrane bending and curvature by mechanisms 
of hydrophobic insertion and/or scaffolding mechanisms (McMahon 
and Gallop, 2005; Zimmerberg and Kozlov, 2006). Two candidate 
BAR domain–containing proteins that interact with EHD1 are the 
N-BAR protein amphiphysin/Bin1 (Pant et al., 2009) and the F-BAR 
protein syndapin2 (Synd2, also known as PACSIN2; see Figure 1A; 
Braun et al., 2005).
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FIGURE 1: MICAL-L1 and Synd2 are direct binding partners that localize to tubular endosomes. (A) Domain 
architecture of MICAL-L1, Synd2, and EHD1. CH, calponin homology domain; LIM, Lin11, Isl-1, Mec-3 domain; 
CC, coiled coil domain; F-BAR, FCH-Bin–amphiphysin–Rvs domain; SH3: Src homology 3 domain; EH, Eps15 
homology domain. (B) Endogenous MICAL-L1 was immunoprecipitated from HeLa cells transfected either with 
HA-tagged Synd2 or JNK1. Coimmunoprecipitation of HA-tagged proteins was examined by immunoblotting with 
anti-HA antibodies. (C) GST pull-down experiments were performed with GST, GST-fusion Synd2, or its truncation/
mutants (as indicated) using bovine brain cytosol. Precipitates were immunoblotted with antibodies for MICAL-L1 
and EHD1. Coomassie blue staining was used to visualize GST and GST-fusion proteins (bottom). (D) Selective 
yeast two-hybrid assays were performed with MICAL-L1 or mutants (as indicated) cotransformed with either 
Synd2 or EHD1. p53 and SV40 serve as controls. (E) HeLa cells were immunostained for endogenous Synd2 and 
MICAL-L1. A profile scan for the region transected by the white line in the merged inset is shown on the right. Bar, 
10 μm.
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cytoplasmic pool (Sharma et al., 2009). To assess whether Synd2 
also alternates between tubular membranes and the cytoplasm, 
we performed fluorescence recovery after photobleaching (FRAP) 
experiments on live cells expressing Tomato-Synd2 and GFP-
MICAL-L1 (Supplemental Figure S3). A region of interest (ROI; 
boxed region) containing a tubular membrane decorated by both 
Tomato-Synd2 and GFP–MICAL-L1 was photobleached using high 
laser intensity, and images were obtained every 30 s by dual-channel 
time-lapse confocal microscopy to monitor recovery of fluorescence 
signal in the ROI. Simultaneous recovery of both MICAL-L1 and 
Synd2 was seen on the tubular membrane within 2 min of photo-
bleaching, and >50% of recovery was seen within 4 min. These data 
provide a strong indication that Synd2 and MICAL-L1 display similar 
dynamics of association with tubular membranes.
The interaction between MICAL-L1 and Synd2 is required 
for their localization to tubular recycling endosomes
We previously showed that MICAL-L1 is required for the recruit-
ment and/or stabilization of EHD1 on tubular recycling endosomes 
(Supplemental Figure S1A; Sharma et al., 2009). The identification 
of Synd2 as a third “marker” of EHD1-MICAL-L1–containing recy-
cling tubules and an interaction partner of both MICAL-L1 and 
EHD1 raised new questions regarding the recruitment of Synd2 to 
these structures. For example, how does Synd2 localize to tubular 
endosomes, and what is the role of each of these three proteins in 
regulating the localization of the other two partners to the tubular 
membranes? To answer these questions, we initially used a deple-
tion approach. As shown by immunoblotting, individual small inter-
fering RNA (siRNA) knockdown of MICAL-L1, Synd2, and EHD1 
caused a depletion of >90% of each protein (with actin as a loading 
control; Figure 2A). Although depletion of either EHD1 or MICAL-
L1 did not affect the expression levels of the remaining two binding 
partners, loss of Synd2 significantly reduced cellular MICAL-L1 
levels (Figure 2A, top, right lane).
We then assessed the effect of siRNA knockdown on the localiza-
tion of the proteins. Similar to mock treatment (Figure 2, B–D), 
EHD1-siRNA treatment did not alter Synd2 or MICAL-L1 localization 
to tubular membranes (Figure 2, E–G). We previously showed that 
MICAL-L1 depletion causes the absence of EHD1 from membrane 
tubules. To determine the mutual relationship between MICAL-L1 
and Synd2, we examined Synd2 localization upon MICAL-L1 deple-
tion. As expected, on MICAL-L1 siRNA treatment, levels of the en-
dogenous protein were undetectable by immunofluorescence 
(Figure 2H). Under these conditions, Synd2 no longer decorated 
tubular membranes but instead appeared dispersed in the cyto-
plasm (Figure 2I). On the other hand, Synd2 depletion (which led to 
nearly undetectable Synd2 levels by immunofluorescence) likely led 
to MICAL-L1 instability and degradation, as observed by both im-
munoblot and immunostaining (Figure 2, A and K–M). The data sup-
port the idea that Synd2 and MICAL-L1 are required for each other’s 
stable localization to tubular recycling endosomes and raise the 
possibility that Synd2 recruitment to membranes is necessary for the 
generation of these structures.
Although we hypothesized that Synd2 regulates receptor recy-
cling in concert with MICAL-L1 and EHD1, it was not possible to test 
this directly, as we found that Synd2 depletion impaired receptor 
internalization (data not shown). This was not surprising, given the 
previously described role for Synd2 in controlling microfilament and 
microtubule networks (reviewed in Kessels and Qualmann, 2004) 
and considering the range of effects we observed upon Synd2 de-
pletion on early endosomes, Golgi, and lysosomes (Supplemental 
Figure S4A).
demonstrated, Synd2 associates with both MICAL-L1 and the four 
EHD proteins by selective yeast two-hybrid (Y2H) assays (Supple-
mental Figure S1C). Y2H experiments were then performed with 
serial truncation mutants of MICAL-L1 to narrow down the PXXP 
motifs used by MICAL-L1 for binding to Synd2 (Supplemental Figure 
S1, D–F). We identified two MICAL-L1 class I PXXP motifs that are 
preceded by basic residues (380KKKPAPLPP and 472KTKKRPAPRAP) 
required for interaction with Synd2 (denoted in Figure 1D as 385PLPP-
ALAP and 480PRAP-ARAA). These PXXP motifs displayed similarity 
with syndapin-binding PXXP motifs in dynamin1 (Supplemental 
Figure S1H). On loss of either PXXP motif in the context of full-length 
MICAL-L1, an interaction with Synd2 was observed; however, loss of 
both PXXP motifs abrogated MICAL-L1–Synd2 binding (Figure 1D). 
Consistent with our pull-down studies, the MICAL-L1 double PXXP 
mutant nonetheless bound to EHD1, whereas a MICAL-L1 NPF mu-
tant (which does not bind EHD1) was still capable of binding to 
Synd2. Mutations in the MICAL-L1 CC domain (721MLVDWF and 
851KR) that affect its ability to bind to membranes (Sharma et al., 
2009) had no effect on MICAL-L1 binding to Synd2 and EHD1, indi-
cating that membrane association is not a prerequisite for MICAL-L1 
to interact with either EHD1 or Synd2. Because MICAL-L1 is capable 
of homo-oligomerization (Supplemental Figure S1G), as are Synd2 
(Qualmann et al., 2011) and EHD1 (Lee et al., 2005), this further sup-
ports the possibility of tripartite MICAL-L1–Synd2–EHD1 complexes 
by three-way direct binding. Moreover, despite the transient nature 
of MICAL-L1 interactions with other proteins, we did observe small 
bands of Synd2 and EHD1 that coprecipitated with MICAL-L1 
(Supplemental Figure S1I), whereas the highly abundant actin did 
not coprecipitate. In addition, EHD3, which displays 86.5% identity 
with EHD1, was precipitated by GST-Synd2 (Supplemental Figure 
S1J) and bound to Synd2 in yeast two-hybrid experiments (Supple-
mental Figure S1C), in agreement with the studies of Braun et al. 
(2005).
We next investigated whether Synd2 localizes to tubular REs. 
Using MICAL-L1 as a known marker for these structures, we 
stained HeLa cells for both endogenous Synd2 and MICAL-L1. In 
addition to its localization to the cytoplasm and vesicular mem-
branes, Synd2 also localized to tubular structures that highly colo-
calized with MICAL-L1 (Figure 1E). The degree of colocalization 
between the endogenous proteins on tubular REs is highlighted 
with a profile scan. When Tomato-Synd2 was exogenously ex-
pressed with green fluorescent protein (GFP)–MICAL-L1, a high 
level of colocalization was observed on tubular membranes (Sup-
plemental Figure S2B, bottom). Even expression of Tomato-Synd2 
alone led to its localization to tubular membranes, although this 
distribution was partially masked by its cytoplasmic pool (Supple-
mental Figure S2B, top left).
We previously showed that the BAR domain–containing protein 
Bin1, also known as amphiphysin1, regulates tubular localization of 
the worm EHD1 orthologue, RME1 in C. elegans (Pant et al., 2009). 
Although Bin1 localizes to recycling endosomes, its loss in mam-
malian cells did not affect the tubular localization of MICAL-L1, 
Synd2, or EHD1 (Supplemental Figures S1, A and B, and S2A). Thus 
endogenous Synd2 and MICAL-L1 continue to display colocaliza-
tion to RE tubules, even in the absence of Bin1 (Supplemental Figure 
S2A), further supporting the notion that Bin1 is not required for RE 
tubule biogenesis. These data lead us to suggest that in mammalian 
cells, the localization of the BAR-domain protein Synd2 to tubular 
RE and its function in a complex with MICAL-L1 and EHD1 are cru-
cial for RE tubule biogenesis.
In previous studies, we determined that both EHD1 and 
MICAL-L1 are dynamically recruited onto tubular membranes from a 
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but clear colocalization to sorting nexin-1 
(SNX1)–containing vesicles (Supplemental 
Figure S4B; mock, see inset). However, 
Synd2 depletion did not have a major ef-
fect on SNX1 localization and did not ap-
pear to diminish the small, SNX1-decorated 
tubules observed in both mock and Synd2-
depleted cells (Supplemental Figure S4B; 
see insets). Because EHD1 also interacts 
with the macropinocytosis regulator Ra-
bankyrin-5 (Zhang et al., 2012b), we tested 
the effect of Synd2 depletion on Ra-
bankyrin-5. In mock-treated cells, a degree 
of colocalization was noted between Synd2 
and Rabankyrin-5 on vesicular structures 
(Supplemental Figure S4B; mock, see in-
set). On Synd2 depletion, we observed a 
modest change in Rabankyrin-5 distribu-
tion to a more peripheral pattern (Supple-
mental Figure S4B; Synd2-siRNA), suggest-
ing a potential relationship between these 
two proteins, possibly through EHD1.
EHD1 stabilizes MICAL-L1/Synd2 
interaction on recycling tubules
Because depletion of MICAL-L1 causes a 
failure of Synd2 to localize to tubular REs, 
we predicted that generation of a MICAL-L1 
protein that lacks the PRD motifs necessary 
for its interaction with Synd2 would lead to 
the absence of both proteins from recycling 
tubules. To test this idea, we used siRNA to 
deplete cells of MICAL-L1 and then reintro-
duced siRNA-resistant versions of MICAL-L1 
as we did previously (Jovic et al., 2009; 
Sharma et al., 2009). As a control we first 
demonstrated that in ∼90% of MICAL-L1–
depleted cells, Synd2 did not localize to 
tubular membranes; however, >85% of 
cells with siRNA-resistant wild-type MICAL-
L1 reintroduced exhibited tubules deco-
rated with both exogenous MICAL-L1 and 
endogenous Synd2, confirming that MICAL-
L1 is required for Synd2 localization to the 
tubular membranes (Figure 3A; quantified in 
Figure 3E).
We then reintroduced an siRNA-resistant 
MICAL-L1 PRD mutant incapable of direct 
interaction with Synd2. Surprisingly, ∼90% 
of cells expressing the MICAL-L1 mutant 
did display both the mutant MICAL-L1 pro-
tein and endogenous Synd2 on tubular en-
dosomes (Figure 3B; quantified in Figure 
3E). We then hypothesized that endoge-
nous EHD1 might link the mutant MICAL-L1 
and endogenous Synd2 on the tubular 
membranes through its homo-oligomeriza-
tion and association with both proteins by 
EH-domain/NPF motif interactions (illus-
trated in Figure 3H). To examine this idea, we first made a MICAL-L1 
siRNA–resistant mutant with a mutation in its first NPF motif that is 
no longer able to bind EHD1 (Sharma et al., 2009). As depicted 
Consistent with the functions described for EHD1 and EHD3 in 
regulation of retromer-based retrograde traffic (Gokool et al., 2007; 
Zhang et al., 2012a,b), endogenous Synd2 displayed a partial 
FIGURE 2: Loss of either MICAL-L1 or Synd2 causes the absence of all known tubular 
endosomal markers from these structures. Mock-treated or siRNA-treated cells were examined 
72 h after treatment. (A) siRNA- and mock-treated cells were immunoblotted for endogenous 
MICAL-L1, Synd2, EHD1, and actin (loading control). (B–M) siRNA- and mock-treated cells were 
immunostained for endogenous MICAL-L1 and Synd2. Bar, 10 μm.
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We then took MICAL-L1–depleted cells and transfected them 
with a MICAL-L1 siRNA–resistant double mutant (PRD plus NPF) in-
capable of interacting with either Synd2 or EHD1. As demonstrated, 
(Figure 3C; quantified in Figure 3E), this mutation still enabled 
Synd2 to localize to tubular endosomes (in ∼80% of the transfected 
cells).
FIGURE 3: Complex interactions between MICAL-L1, Synd2, and EHD1 in tubular localization and biogenesis. 
(A–D) Cells treated for 72 h with MICAL-L1 siRNA were transfected for the last 48 h with either siRNA-resistant, 
wild-type, HA-tagged MICAL-L1 or mutant constructs. The cells were then immunostained with anti-HA and anti-Synd2 
antibodies. Bar, 10 μm. (E) HeLa cells treated as in A were quantified to assess the percentage of cells with Synd2 
localized to tubular membranes. Error bars, SE. (F) Cells treated for 72 h with Synd2 siRNA were transfected for the last 
48 h with siRNA-resistant, wild-type, HA-tagged Synd2. Cells were then immunostained with anti-HA and anti–MICAL-L1 
antibodies. Bar, 10 μm. (G) HeLa cells treated as in F were quantified to assess the percentage of cells with MICAL-L1 
localized to tubular membranes. Error bars, SE. (H) Model illustrating the interaction profile between MICAL-L1, Synd2, 
and EHD1.
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of transferrin and its receptor (Supplemental Figure S7). Overall 
these data lend support to the idea that phosphatidic acid is an in 
vivo component of tubular recycling endosomes.
To determine whether recycling endosomes require PA for their 
tubular shape and function in recycling, we used several inhibitors 
expected to reduce cellular PA levels. There are three described 
pathways for PA production (Figure 5A): 1) conversion of phosphati-
dylcholine (PC) to PA by the lipase activity of phospholipase D (PLD), 
2) conversion of diacylglycerol (DAG) to PA by the kinase activity of 
DAG kinase, and 3) conversion of lysophosphatidic acid (LPA) to PA 
by the acyltransferase activity of LPA acyltransferase. On the other 
hand, PA is catabolized to LPA and DAG by phospholipase A and PA 
phosphatase, respectively.
We used the drug R59949 and a combination of the inhibitors 
CAY10593 and CAY10594 (which block DAG kinase and PLD activ-
ity, respectively). We then measured intracellular PA as described 
(Morita et al., 2009) and found that in comparison to dimethyl sul-
foxide (DMSO)–treated control cells, R59949 or CAY treatment re-
duced cellular PA levels to <40 and 60%, respectively (Figure 5B). 
However, the drugs did not alter either MICAL-L1 or Synd2 cellular 
expression (Figure 5C). On the other hand, PA reduction by the 
drugs dramatically altered the localization of both endogenous 
MICAL-L1 and Synd2 (Figure 5, D and E). Whereas >80% of DMSO-
treated cells displayed MICAL-L1 localized to tubular endosomes, 
this was decreased to <30 and 20% of the R59949 and CAY drug-
treated cells, respectively Figure 5E). These data led us to conclude 
that PA is required for the normal localization of both MICAL-L1 and 
Synd2 to recycling endosomes and likely a significant factor for RE 
tubule biogenesis.
Because both MICAL-L1 and Synd2 interact with EHD1 and are 
involved in membrane recycling, we next tested whether decreased 
levels of cellular PA affect receptor recycling. Cells were incubated 
with dye-labeled transferrin (Tf) for 20 min to allow internalization 
and accumulation in the ERC (Figure 5F). These cells were then 
mock treated with DMSO or either R59949 or the CAY drugs for 1 h 
in serum-containing media (chase) to assess the recycling of Tf. As 
expected, over this time the DMSO-treated cells exhibited active 
recycling and retained <11% of the internalized Tf within the cell 
(Figure 5, G and J). On the other hand, there was >50% increase in 
the nonrecycled Tf in R59949-treated cells, representing a statisti-
cally significant difference (Figure 5, H and J). More dramatically, we 
found that cells treated with the two CAY drugs retained >70% of 
their internalized Tf, indicating a severe delay in recycling (Figure 5, 
I and J). Although both sets of inhibitors induce relatively similar 
decreases in overall cellular PA levels (Figure 5B), differences in their 
effect on recycling might stem from the localized action of the en-
zymes (PLD and DAG kinase) or potentially be due to additional, 
as-yet-uncharacterized effects of the inhibitors.
Synd2 preferentially tubulates liposomes containing PA
Given the role of PA in recruitment of MICAL-L1 and Synd2 to recy-
cling endosomes and the ability of BAR domain–containing proteins 
such as Synd2 to tubulate membranes, we next calibrated an in vitro 
assay to test whether Synd2 preferably tubulates large multilamellar 
vesicles (LMVs) that are enriched in PA. Without addition of any pro-
tein to the liposomes, no tubulation was observed with liposomes 
containing PC and PE or PC and PA (Figure 6, A and B). As depicted, 
and consistent with previous studies (Wang et al., 2009), the 
full-length Synd2 displayed little or no tubulation of LMVs com-
posed of PC/PE (Figure 6C). Indeed, changing the LMV composition 
from PC/PE to PC/PA did not enhance tubulation by full-length 
Synd2 (Figure 6D). However, the isolated F-BAR domain of Synd2 
in ∼80% of transfected cells the double mutant MICAL-L1 neither 
localized to tubular endosomes nor recruited Synd2 to these struc-
tures (Figure 3D; quantified in Figure 3E), suggesting that EHD1 can 
link MICAL-L1 and Synd2 on these membranes via its EH domain. 
Similar knock-in studies were performed on Synd2 siRNA–treated 
cells. Whereas <15% of Synd2-depleted cells exhibited MICAL-L1 
localized to tubular membranes, reintroducing siRNA-resistant 
Synd2 significantly increased MICAL-L1 associated with tubular 
membranes in >70% of transfected cells (Figure 3F; quantified in 
Figure 3G). On the basis of these data, we suggest that a tripartite 
interaction between MICAL-L1, Synd2, and EHD1 (Figure 3H) con-
trols association with recycling tubules and their biogenesis.
MICAL-L1 and Synd2 are phosphatidic acid–binding 
proteins
Little is known about the lipid selectivity that regulates MICAL-L1 
and Synd2 binding to lipid bilayers. Whereas Synd2 binds to lipids 
through its BAR domain (reviewed in Qualmann et al., 2011), 
MICAL-L1 requires its C-terminal coiled-coil (CC) region to localize 
to tubular REs (Figure 4A; Sharma et al., 2009). To determine the 
preference of lipid binding, we purified the Synd2 F-BAR domain 
and the MICAL-L1 CC domain. Because the MICAL-L1 CC domain 
was highly insoluble, denaturation and renaturation steps were 
required (Supplemental Figure S5, A–C), and the renatured histidine 
(His)-tagged CC domain was analyzed by circular dichroism to 
ensure proper folding of the amphipathic α-helical structure 
(Supplemental Figure S5D).
We then performed lipid overlay assays with His-tagged MICAL-
L1 CC domain and the GST-Synd2 F-BAR domain, as well as with the 
full-length GST-Synd2 protein (Figure 4B and Supplemental Figure 
S6, A and B). Both proteins showed a degree of selectivity for PA 
under these conditions. Synd2 also bound to phosphatidylserine 
(PS; Figure 4B, and Supplemental Figure S6, A and B), but its iso-
lated F-BAR domain displayed less selectivity to PS than to PA (Sup-
plemental Figure S6A, middle and right).
To examine the PA binding of both proteins under more physio-
logical conditions, we used a liposome flotation assay. In these ex-
periments, the tagged proteins were incubated with rhodamine-
labeled liposomes comprising varying lipids and subjected to a 
stepwise sucrose gradient and ultracentrifugation. A linear sucrose 
gradient was established, with >80% of the liposomes present in the 
top layer (Figure 4C, schematic diagram and graph). Under these 
conditions, we observed that both Synd2 F-BAR and the MICAL-L1 
CC domain were present in the top fraction in PA-containing lipo-
somes but not in liposomes lacking PA. This supports the notion that 
Synd2 and MICAL-L1 are PA-binding proteins.
Phosphatidic acid is a key component of tubular REs
On characterizing both Synd2 and MICAL-L1 as PA-binding pro-
teins, we hypothesized that the presence of PA on recycling endo-
somes might enable the binding of these proteins to membranes. 
To test this in vivo, we transfected cells with the well-characterized 
PA probe Spo20p (residues 51–91) tagged to GFP (Zeniou-Meyer 
et al., 2007). This probe partially colocalized with MICAL-L1 on tu-
bular REs, whereas a mutant incapable of PA binding (Spo20p-L67P-
PABD) was mostly cytosolic and displayed no colocalization with 
MICAL-L1 (Supplemental Figure S6C). Overexpression of the MI-
CAL-L1 CC domain, which retains its localization to tubular endo-
somes (Sharma et al., 2009) and is unable to bind to Synd2 or EHD1, 
did not compete with binding of either endogenous MICAL-L1 or 
endogenous Synd2 to tubular recycling endosomes (Supplemental 
Figure S6D). Similarly, it did not affect the internalization or recycling 
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observed in PC/PE LMVs (Figure 6G); however, we did detect the 
generation of tubular structures when the MICAL-L1 CC was incu-
bated with LMVs containing PC/PA (Figure 6H). Both phosphati-
dylinositol 4,5-bisphosphate (PI(4,5)P2) and PS were also tested in 
PC LMVs (Supplemental Figure S8). PS-containing LMVs displayed 
(known to be active in membrane tubulation; Wang et al., 2009) in-
duced extensive tubulation of LMVs containing PC/PA as compared 
with PC/PE (Figure 6, compare F and E). Although the MICAL-L1 CC 
domain does not display homology to BAR domains, we neverthe-
less tested its ability to tubulate LMVs. As shown, no tubulation was 
FIGURE 4: MICAL-L1 and Synd2 are phosphatidic acid–binding proteins. (A) HeLa cells transfected with HA–MICAL-L1 
CC domain were immunostained for endogenous MICAL-L1 and HA tag. Bar 10 μm. (B) His–MICAL-L1 CC domain and 
GST-Synd2 were subjected to a lipid overlay assay and immunoblotted with antibodies for their respective tags. The 
concentration of the lipids is indicated on the top. (C) His–MICAL-L1 CC and GST-Synd2 F-BAR domains were subjected 
to liposome flotation assays (depicted schematically). Liposome fractions (bottom [B], middle [M], top [T]) were 
immunoblotted with antibodies for the respective protein tag. The distribution of liposomes in each fraction 
postcentrifugation from six experiments is displayed as a graph. Error bars, SE.
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DISCUSSION
RE tubules are important for the efficient sorting and recycling of 
internalized cargo and lipids back to the plasma membrane (Jovic 
et al., 2009). Despite the existence of this unique network of inter-
twined tubules and vesicles that comprise the ERC (Maxfield and 
McGraw, 2004), little is known about the biogenesis of this complex 
organelle or even about the biogenesis of individual tubular REs. 
some spontaneous tubulation, which was enhanced by the Synd2 
F-BAR domain (Supplemental Figure S8, A, C, E, and G). However, 
in our hands PI(4,5)P2-containing LMVs displayed no tubulation un-
der any conditions (Supplemental Figure S8, B, D, F, and H). Taken 
together, these data show that the PA-binding proteins, MICAL-L1, 
and Synd2 are capable of generating tubules from PA-containing 
membranes.
FIGURE 5: Phosphatidic acid controls generation and trafficking through tubular recycling endosomes. (A) Metabolic 
pathways leading to phosphatidic acid synthesis. (B) PA levels were quantified enzymatically in HeLa cells treated with 
the indicated drugs for 1 h (compared with DMSO control treatment) from three independent experiments. Error bars, 
SE. (C) Cells treated as in B were immunoblotted for MICAL-L1, Synd2, and actin (loading control). (D) Cells treated as in 
B were immunostained for endogenous MICAL-L1 and Synd2. Bar, 10 μm. (E) Quantification of the percentage of cells 
from D with MICAL-L1 localized to tubular membranes from three independent experiments. Error bars, SE. (F–I) Cells 
incubated with Alexa Fluor 568–labeled transferrin for 20 min were either fixed (pulse) or fixed after 1 h treatment with 
the indicated drugs (chase). Bar, 10 μm. (J) HeLa cells incubated with Alexa Fluor 633–labeled transferrin for 30 min 
were fixed after 1 h treatment with DMSO (control) or the indicated drugs. The percentage of nonrecycled transferrin 
remaining in the cell was analyzed by flow cytometry from three independent experiments. Error bars, SE.
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The BAR domain–containing protein Bin1 interacts with both the 
C. elegans Rme1/EHD1 orthologue and the human EHD1 protein 
and in vitro is capable of inducing tubulation of lipid monolayers 
(Pant et al., 2009). It is also necessary for Rme1 tubulation in worms. 
However, our experiments suggest that in human cells Bin1 is not 
Since identifying MICAL-L1 as an EHD1 interaction partner and RE 
tubule marker, our previous studies have demonstrated that EHD1 
is not required for the biogenesis of these tubules in vivo (Sharma 
et al., 2009), suggesting the involvement of other proteins in this 
process.
FIGURE 6: Phosphatidic acid–rich LMVs undergo tubulation in the presence of F-BAR domain of Synd2 and CC domain 
of MICAL-L1. In vitro tubulation assays were performed with (A) PE-containing liposomes only, (B) PA-containing 
liposomes only, (C) PE-containing liposomes and GST-Synd2, (D) PA-containing liposomes and GST-syndapin, 
(E) PE-containing liposomes and GST-Synd2-F-BAR, (F) PA-containing liposomes and GST-Synd2-F-BAR, (G) PE-containing 
liposomes and His-MICAL-L1-CC, or (H) PA-containing liposomes and His-MICAL-L1-CC. LMVs comprised a mass ratio of 
70% PC, 10% NBD-PE, and 20% PE or PA. Insets depict the region in the white box. Bar, 10 μm.
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conditions were used. We propose that due to the symmetrical 
nature of PA and its tendency to eliminate spontaneous curvature 
(as opposed to lysophospholipids; reviewed in (Graham and 
Kozlov, 2010), the local concentration of PA in membranes may 
further facilitate Synd2 F-BAR domain–induced tubulation.
Our data support a novel model for the biogenesis of RE tubules 
(Figure 7). Through the generation and/or concentration of PA in 
membranes (Figure 7A), MICAL-L1 and Synd2 are recruited via their 
coiled-coil and BAR domains, respectively (Figure 7B). The direct 
interaction between MICAL-L1 and Synd2 (via 2 of the former’s 14 
PRDs and the latter’s SH3 domain) stabilizes their localization on 
membranes (Figure 7C). This in turn would allow the amphipathic 
BAR domain to insert within the membrane and induce curvature 
that drives the tubulation (Farsad and De Camilli, 2003; Drin and 
Antonny, 2010; Rao et al., 2010) that is typical for RE membranes 
(Figure 7D). We expect that the recruitment of EHD1 and other fac-
tors later drive the fission of vesicles from these tubular REs (Figure 
7E), generating recycling carriers of receptors and membranes 
bound for the plasma membrane (Daumke et al., 2007; Jakobsson 
et al., 2011; Cai et al., 2012).
The role of PA in RE tubule biogenesis is ambiguous. Several 
studies showed that the lysophosphatidic acid acyl transferase in-
hibitor (see Figure 5A) CI-976 induces tubulation of Golgi, COP1 
vesicles, and even recycling endosomes (Chambers et al., 2005; 
Yang et al., 2011). In HeLa cells, we measured only a ∼27% decrease 
in PA levels upon CI-976 treatment (compared with 43 and 62% re-
duction for CAY and R59949 inhibitors, respectively); however, this 
does lead to decreased MICAL-L1–containing recycling tubules 
(unpublished observations). Moreover, the studies by Chambers 
et al. (2005) address the generation of much shorter, thinner, and 
labile tubules visualized with internalized transferrin as a marker. It is 
possible that PA supports the generation of long, wide, and stable 
MICAL-L1–containing tubules, whereas LPA (increased upon CI-976 
treatment) promotes the generation of shorter, thinner tubules to 
which transferrin localizes.
A recent study determined that reduction of PA levels in cells 
leads to decreased clathrin-coated pit formation, slower budding 
from the plasma membrane, and reduced rate of epidermal growth 
factor receptor internalization (Antonescu et al., 2010). Although it 
was reported that phospholipase D2 (PLD2) affects transferrin re-
ceptor recycling (Padron et al., 2006), and PLD2 indirectly controls 
cellular PA levels, little is known about the role of PA in controlling 
endocytic recycling. Given that PA also stimulates PIP5 kinase, which 
in turn generates PI(4,5)P2 (Moritz et al., 1992; Jenkins et al., 1994), 
it is possible that PLD inhibition might affect recycling by decreasing 
PI(4,5)P2 levels, as well as PA levels (Padron et al., 2006). Indeed, 
PI(4,5)P2 is also an essential phospholipid for RE tubules (Jovic et al., 
2009). In fact, although our enzymatic PA measurement showed 
similar levels of PA decrease with either PLD or diacylglycerol kinase 
inhibitors, the more robust inhibition of endocytic recycling that we 
observed with the PLD inhibitors might be due to indirect effects on 
PI(4,5)P2, phosphatidylinositol 4-phosphate, and other phospho-
inositides. Moreover, given that Arf6 activation stimulates PA gen-
eration (Brown et al., 1993; Jovanovic et al., 2006), it is noteworthy 
that Arf6 depletion causes the removal of MICAL-L1 from tubular RE 
(Rahajeng et al., 2012), leading to the notion that this occurs indi-
rectly as a result of PA inhibition.
In summary, we provide evidence promoting a new model in 
which MICAL-L1 and Synd2 are recruited to RE by direct interac-
tions with PA, which we now demonstrate is an important lipid for 
RE tubule biogenesis and efficient endocytic recycling. EHD1 is 
likely recruited onto preexisting tubules, where it acts as part of the 
essential for the biogenesis of RE tubules decorated by EHD1 and 
MICAL-L1 (Supplemental Figures S1A and S2A). On the other hand, 
our discovery that the EHD1 interaction partner and F-BAR–contain-
ing protein Synd2 directly interacts with MICAL-L1 has led to the 
notion that Synd2 may be essential for RE tubule biogenesis. It is 
noteworthy that mammalian Bin1 lacks the EH domain–binding NPF 
motif that is found in the worm orthologue, whereas the worm syn-
dapin lacks the NPF motif present in mammalian orthologues. Thus 
it is possible that different BAR domain proteins play variable roles 
in the process of RE tubule biogenesis in different species.
Syndapin proteins, including the ubiquitously expressed 
Synd2 (also known as PACSIN2), interact with EHD1 (Xu et al., 
2004; Braun et al., 2005) and are implicated in the regulation of 
endocytic events (Modregger et al., 2000; Qualmann and Kelly, 
2000). More recently, Synd2 was identified as an important pro-
tein in the generation of caveolar membranes (Hansen et al., 
2011; Senju et al., 2011) and the regulation of Rac1-mediated cell 
spreading and migration (de Kreuk et al., 2011). However, the po-
tential role of Synd2 in RE tubule biogenesis has not been 
examined.
Given that all three proteins, EHD1, MICAL-L1, and Synd2, in-
teract with one another and decorate tubular RE, a key issue is 
how they are recruited to REs. Given that MICAL-L1 recruits EHD1 
to these membranes (Sharma et al., 2009), our goal was to deter-
mine whether MICAL-L1 or Synd2 is first recruited to REs or they 
simultaneously associate with the membranes. Indeed, depletion 
of either protein caused the removal of its partner from these 
structures, and FRAP experiments display nearly identical dynam-
ics of recruitment to tubules for each protein. Because the recov-
ery of these proteins occurs along the entire length of the tubule, 
this suggests that there is stable MICAL-L1–Synd2 binding even 
after tubule generation, hinting that the complex may play an 
additional function in these membrane structures, such as the 
recruitment of EHD1.
Synd2 depletion results in decreased MICAL-L1 expression, sug-
gesting that the latter is destabilized when not associated with 
Synd2 on membranes. As we anticipated, the reintroduction of 
wild-type MICAL-L1 into depleted cells results in the recruitment 
and stabilization of Synd2 on RE tubules with MICAL-L1. We were 
initially surprised that a MICAL-L1 PRD mutant (incapable of inter-
acting directly with Synd2) nonetheless localized to tubular mem-
branes and induced the recruitment of Synd2 to these structures. 
However, we reasoned that this may be due to an indirect interac-
tion between MICAL-L1 and Synd2 through EHD1; indeed, a dou-
ble MICAL-L1 mutant incapable of interacting with either Synd2 or 
EHD1 no longer localized to RE tubules, nor did it recruit Synd2 to 
these structures.
Given that both MICAL-L1 and Synd2 appear to be recruited to 
RE membranes with similar kinetics, we determined the lipid bind-
ing of each protein. Under the conditions we used, our data led to 
the notion that both proteins bind PA. Because there are only a 
handful of known PA-binding proteins (reviewed in Stace and 
Ktistakis, 2006; Kassas et al., 2012), the identification of a PA-bind-
ing consensus is problematic. However, the well-characterized 
yeast protein Spo20p PA-binding domain clearly localized to 
MICAL-L1–containing tubular RE, indicating that these tubules in-
deed contain PA in vivo. Moreover, in vitro tubulation assays indi-
cate that the Synd2 F-BAR domain (and the MICAL-L1 CC) displays 
preference for tubulating liposomes containing PA. Although Synd1 
and Synd2 can bind liposomes comprising PC/PS (Dharmalingam 
et al., 2009), in contrast to our study, in these experiments the 
conditions of Bigay et al. (2005) were modified so that low-salt 
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epitope (Covance, Princeton, NJ); mouse anti-EEA1 (BD Biosci-
ences, San Jose, CA); mouse anti-hexahistidine tag, mouse anti-
actin, and rabbit anti-giantin (Abcam, Cambridge, MA); goat anti-
GST conjugated to horseradish peroxidase (HRP; GE Life Sciences, 
Piscataway, NJ); mouse anti-lamp1 (Developmental Studies Hybri-
doma Bank, Iowa City, IA); mouse anti-SNX1 (BD Biosciences); 
mouse anti–Rabankyrin-5 (Abnova, Walnut, CA); rabbit anti-HA 
(Signalway Antibody, Pearland, TX); and polyclonal rabbit anti-
EHD1 (Naslavsky et al., 2004). Secondary antibodies Alexa Fluor 
568–conjugated goat anti-mouse, Alexa Fluor 488–conjugated 
fission machinery to allow vesicular transport onto the plasma 
membrane.
MATERIALS AND METHODS
Antibodies and reagents
The following primary antibodies were used: mouse polyclonal 
anti–MICAL-L1 (Novus Biologicals, Littleton, CO); rabbit poly-
clonal anti-Synd2 purchased from Abgent (San Diego, CA; for im-
munofluorescence) and Proteintech (Chicago, IL; for Western 
blot); rabbit polyclonal anti-Bin1 (Proteintech); mouse anti-HA 
FIGURE 7: Model for biogenesis of tubular recycling endosomes. (A) Phosphatidic acid is generated or enriched on 
membranes. (B) MICAL-L1 (via its CC domain) and Synd2 (via its F-BAR domain) are recruited to PA-enriched 
membranes. (C) The MICAL-L1 PXXP motifs interact with the SH3 domain of Synd2 to stabilize both proteins on the 
membranes and (D) facilitate the generation of tubular endosomes by Synd2. (E) Synd2 and MICAL-L1 bind to the EH 
domain of EHD1 via their NPF motifs and recruit EHD1 to these tubular membranes, potentially facilitating vesiculation.
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Tf-633 by flow cytometry analysis. To study the effect of exogenous 
expression of the MICAL-L1-CC domain on endocytic recycling 
(Supplemental Figure S7), HeLa cells were transiently transfected 
with HA–MICAL-L1 CC domain for 16 h and incubated with Tf-568 
for 5 min. Cells were fixed either immediately or after incubation 
with DMEM containing 10% serum for the indicated time period.
Phosphatidic acid measurement
Cellular PA levels were measured using an enzymatic assay de-
scribed by Morita et al. (2009). Briefly, cells were treated with drugs 
(as indicated) for 1 h, and lipids were extracted from cells using the 
Bligh–Dyer lipid extraction method (Bligh and Dyer, 1959). Lipids 
were then dried under flow of nitrogen and suspended in 2% Triton 
X-100. Lipids were then incubated with lipoprotein lipase generated 
from Burkholderia sp. (Sigma-Aldrich), followed by incubation with 
glycerol-3-phosphate oxidase (from Aerococcus viridans; Sigma-
Aldrich), horseradish peroxidase (Sigma-Aldrich), and Amplex red 
(Invitrogen). Fluorescent resorufin, the end product of this enzymatic 
assay, was analyzed for its fluorescence with excitation at 544 nm 
and emission at 590 nm. A standard curve was generated for each 
experiment using egg-PA (Avanti Polar Lipids, Alabaster, AL) to 
check whether PA measurements made were within the linear range. 
Protein content measured by Bradford assay was used for normal-
ization. Finally, PA values in treated cells were normalized to that of 
DMSO-treated cells for each experiment.
Immunoprecipitation and GST pull-down
HeLa cells transiently transfected with either HA-Synd2 or HA-JNK1 
(Figure 1B) or coexpressed with both HA-Synd2 and GFP-Myc-EHD1 
(Supplemental Figure S1I) were lysed in buffer containing 50 mM 
Tris-HCl (pH 7.4), 150 mM NaCl, 1% Brij 98, 10 mM iodoacetamide, 
250 μM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, 
10 μM leupeptin, and 10 μM aprotonin. Cell lysates were incubated 
with MICAL-L1 antibodies overnight, followed by incubation with 
protein L agarose beads (Fisher Thermo Scientific, Waltham, MA) for 
2 h at 4°C. The beads were washed three times in wash buffer 
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Brij 98, 1.8 mg/ml 
iodoacetamide), eluted with 4× sample buffer, and subjected to 
immunoblotting.
To address the binding of Synd2 to MICAL-L1 and EHD1 (Figure 
1C), GST-fusion proteins of Synd2 (50 μg each) immobilized onto 
GST beads were incubated with bovine brain cytosol (BBC; pre-
pared in 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
[HEPES], 100 mM NaCl, 1 mM EDTA, pH 7.4, 0.5% Triton X-100, and 
protease inhibitors) overnight and with two additional rounds of 
BBC incubation, each for 2 h at 4°C. Beads were then washed 3× in 
phosphate-buffered saline containing 0.1% TX-100, eluted with 4× 
sample buffer, and analyzed by immunoblotting.
To address the binding of Synd2 to EHD3 (Supplemental Figure 
S1J), HeLa cells were transfected with either GFP or GFP-EHD3 for 
48 h, lysed in 1% Brij lysis buffer, and incubated with 50 μg of Synd2 
immobilized to GST beads overnight. The beads were then washed 
3× with 0.1% Brij wash buffer, eluted with 4× sample buffer, and 
subjected to immunoblotting.
Yeast two-hybrid study
Yeast two-hybrid study was performed as previously described 
(Naslavsky et al., 2006). The Saccharomyces cerevisiae strain AH109 
was cotransformed with the mentioned constructs using lithium ac-
etate procedure and allowed to grow at 30°C after streaking on 
plates lacking leucine and tryptophan. Once the colonies grew large 
enough, an average of three to four colonies were chosen, 
goat anti-mouse, and Alexa Fluor 568–conjugated goat anti-
rabbit antibodies were purchased from Invitrogen. HRP conju-
gated to goat anti-mouse and donkey anti-rabbit were obtained 
from Jackson ImmunoResearch Laboratories (West Grove, PA) 
and GE Life Sciences, respectively. Tf-568 and Tf-633 was pur-
chased from Invitrogen. Brij 98 and R59949 were obtained from 
Sigma-Aldrich (St. Louis, MO). CAY10593 and CAY10594 were 
purchased from Cayman Chemical Company (Ann Arbor, MI).
Constructs
Cloning of EHD1, EHD2, EHD3, EHD4, and MICAL-L1 into yeast 
two-hybrid vectors pGBKT7 and pGADT7, as well as cloning of HA–
MICAL-L1, HA–MICAL-L1 resistant to siRNA treatment, and GFP-
Myc–EHD1, was as described (Caplan et al., 2002; Sharma et al., 
2009). Two-hybrid control vectors (Gal4ad-SV40 large T-antigen and 
Gal4bd-p53) were purchased from Clontech (Palo Alto, CA). Human 
Synd2 (longer isoform) was PCR amplified from HeLa cDNA and 
cloned into pGBKT-7 and the hemagglutinin fusion mammalian ex-
pression vector pHA-CMV (Clontech), using standard procedures. 
Synd2 was subcloned into the GST fusion bacterial expression vec-
tor pGEX-6P2 (GE Life Sciences), which was later truncated at resi-
dues 280 (F-BAR) and 430 (ΔSH3) or mutated at all of its NPF motifs 
to APA (NPF → APA) using QuikChange Site-Directed Mutagenesis 
Kit (Stratagene, La Jolla, CA). siRNA-resistant Synd2 was created 
similarly by generating CDNA mutation at the oligonucleotide-
binding region. The SH3 domain of Synd2 (residues 426–486) was 
cloned into pGEX-6p2. MICAL-L1 residues 700–863 constituting the 
CC domain was cloned into the His-tag fusion bacterial expression 
vector pET-14b (Novagen, Madison, WI). MICAL-L1 residues 368–
468 and 468–863 were cloned into pGADT7. Truncation and muta-
tions in MICAL-L1 full length, MICAL-L1 resistant to siRNA treat-
ment, and residues 368–468 and 468–863 (present in mammalian 
and yeast-two hybrid vectors) were generated using QuikChange 
Site-Directed Mutagenesis Kit. HA-JNK1 was a kind gift from Sylvio 
Gutkind (National Institutes of Health, Bethesda, MD).
Cell culture, transfections, and siRNA treatment
HeLa cells were grown in DMEM containing with 10% fetal bovine 
serum (Sigma-Aldrich). HeLa cells were transfected with either 
FuGENE 6 or FuGENE HD (Roche Diagnostics, Indianapolis, IN). 
On-Target SMART Pool siRNA from Dharmacon (Lafayette, CO) for 
MICAL-L1, Synd2, and Bin1 and siRNA duplexes for EHD1 (base 
pairs gaaagagatgcccaatgtc, synthesized by Dharmacon) were trans-
fected using Dharmafect (Dharmacon) to perform knockdown stud-
ies as previously described (Naslavsky et al., 2006).
Immunofluorescence
Cells were fixed with 4% paraformaldehyde and immunostained as 
previously described (Naslavsky et al., 2006). Images were acquired 
using a Zeiss LSM 5 Pascal confocal microscope (Carl Zeiss, Jena, 
Germany) by using a 63×/1.4 numerical aperture objective with 
appropriate filters.
Transferrin uptake assays
To study the role of PA in endocytic trafficking (Figure 5, F–J), HeLa 
cells were starved in DMEM media containing 0.5% bovine serum 
albumin (BSA) for 1 h and pulsed with 1 μg/ml of either Alexa Fluor 
568–labeled transferrin (Tf-568) for 20 min for microscopy studies or 
Alexa Fluor 633–labeled transferrin (Tf-633) for 30 min for quantifica-
tion by flow cytometry. Cells were either fixed immediately or fixed 
after incubation with DMEM containing 10% serum and the indi-
cated drug for 1 h. At least 10,000 cells were analyzed for internal 
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suspended in water, equilibrated to the same optical density at 
600 nm, and replated on plates lacking leucine and tryptophan 
(+His), as well as plates also lacking histidine (–His).
Lipid overlay assay
Lipid overlay assay was as previously described (Naslavsky et al., 
2007). Briefly, phosphatidylinositol (PIP) strips, PIP arrays, Sphin-
goStrips, and membrane arrays (Echelon Biosciences, Salt Lake City, 
UT) were blocked in TBST-BSA (10 mM Tris, pH 8.0, 150 mM NaCl, 
0.1% Tween-20 [vol/vol]) supplemented with 3% BSA for 1 h at room 
temperature and then incubated with 1 μg/ml GST or His-tag fusion 
protein diluted in TBST-BSA overnight at 4°C. After washes with 
TBST-BSA, the strips were immunoblotted for their respective tags.
Liposome flotation assay
Liposome preparation was performed as described by Pant et al. 
(2009). Lipids solubilized in chloroform were purchased from Avanti 
Polar Lipids. Liposomes were prepared in mass ratio composition 
of 85% PC, 5% rhodamine-labeled phosphatidyl ethanolamine, 
and 10% PC, PE, PA, PS, or PI(4,5)P2. Lipids were mixed in glass-
ware that was washed in chloroform and dried under nitrogen gas. 
Lipids were dried in a stream of nitrogen gas and incubated in 
vacuum overnight. Dried lipids were then resuspended to a con-
centration of 1.65 mg/ml in liposome-binding buffer (LBB; 20 mM 
HEPES, pH 7.4, 150 mM NaCl, 1 mM MgCl2) and were extruded on 
Mini-Extruder (Avanti Polar Lipids) through 200-nm polycarbonate 
track-etched membrane filters to produce liposomes of 200-nm 
diameter.
Liposome flotation assay was adapted from protocol described 
by Bigay et al. (2005). Briefly, 5 μg of protein was incubated with 
150 μl of rhodamine-labeled liposomes (at a 1 mg/ml concentra-
tion) or LBB buffer at room temperature for 15 min. This suspension 
was mixed with 100 μl of LBB containing ice-cold 75% sucrose, re-
sulting in a 30% sucrose solution, which was overlaid with 200 μl of 
25% sucrose and 150 μl of 0% sucrose solution prepared in ice-cold 
LBB. This sample was centrifuged at 200,000 × g for 1 h at 4°C in a 
Beckman swinging rotor (SW 60 Ti). The top 150 μl (T), middle 
200 μl (M), and bottom 250 μl (B) were manually collected from the 
top and analyzed for fluorescence at excitation and emission of 544 
and 590 nm, respectively, to quantitate the average percentage of 
liposome present in each fraction. Equal volumes of fractions were 
run on SDS–PAGE and immunoblotted for their respective tags.
Lipid tubulation assay
The lipid tubulation assay was adapted from Quan et al. (2012). 
Liposomes were prepared as described in the mass ratio of 70% 
PC, 10% NBD-PE (Invitrogen), and 20% PE, PA, PS, or PIP2. Dried 
lipids were hydrated in LBB for 1 h at 37°C and then vortexed and 
pipeted to form MVLs. Liposomes of 1 mg/ml concentration (in a 
volume of 100 μl) were incubated with 5 μg (Synd2 or Synd2–F-
BAR) or 2 μg (MICAL-L1 CC) of the protein of interest at room 
temperature for 15 min. Later this liposome–protein mixture was 
diluted in LBB to a liposome concentration of 0.33 mg/ml, and 5 μl 
of this mixture was spotted onto a coverglass and hydrated at room 
temperature for 15 min. Liposomes on coverglasses were mounted 
and analyzed.
Statistical analysis
Data sets were analyzed by Student’s one-tailed paired t test analy-
sis, and data were considered significantly different for p < 0.05. The 
p values are shown for each experiment.
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